Does a relationship exist between blood groups and gastro-oesophageal junctional tumours?  by Barnes, Rachel et al.
Abstracts / International Journal of Surgery 10 (2012) S53–S109S92
ABSTRACTSwere repaired laparoscopically. ASA grade and pre-operative shock inde-
pendently predictedmortality (p<0.01). ASA grade predictedmorbidity (p
<0.01). Patients with Boey Score of 0, 1, 2 and 3 had 0, 6, 55 and 100%
mortality respectively.
Conclusions: Our 30-day mortality of 14.6% compares to published ﬁgures
of 4-31%. Morbidity of 50% was higher than expected which may be due to
deﬁnition or case mix. The development of guidelines for managing
perforated ulcer would permit comparison of outcomes between centres.
Future directions for improving care include management of sepsis and
use of laparoscopic surgery.
0482: DOES A RELATIONSHIP EXIST BETWEEN BLOOD GROUPS AND
GASTRO-OESOPHAGEAL JUNCTIONAL TUMOURS?
Rachel Barnes, Rhiannon Bowen, Timothy Havard, Xavier Escofet. Royal
Glamorgan Hospital, Llantrisant, UK
Aims: Many studies have been carried out to investigate the association of
blood group antigens and disease. Cancers in general appear to be associated
with group A and to a lesser extent group B. This study aimed to establish
whether there is a positive association between inherited blood group anti-
gens and the development of Gastro-oesophageal junctional (GOJ) tumours.
Methods: A retrospective analysis of a prospectively maintained database
to identify all patients with GOJ tumours from 2000-2010. The blood
groups and data on other risk factors were collected and compared with
information from theWelsh Blood Service on the relevant catchment area.
Statistical analysis was performed using the Chi squared test.
Results: 210 patients were diagnosed with GOJ tumour (79% male). Age
range 31- 89 years (mean 68 years). All patients were Caucasian. The
distribution of blood groups within the patient cohort was comparable to
that of the general population within the catchment area (p¼ 0.062- 0.9).
Conclusion: There appears to be no association between blood groups and
the development of gastro-oesophageal cancer. Larger scale studies will be
required.
0530: FAST TRACK UPPER GASTROINTESTINAL SURGERY – A
SYSTEMATIC REVIEW
Dilan Dabare, Vanash Patel, Emmanouil Zacharakis. Queen Alexandra
Hospital, Southsea, Portsmouth, UK
Aims: The aim of this systematic review was to evaluate the feasibility of
fast track surgery in upper gastrointestinal surgery.
Methods: A systematic review was performed by searching EMBASE, Med-
line, PsycINFO and Cochrane Library. The search strategy included the
keywords: fast track, enhanced recovery and multimodal rehabilitation/
optimization/perioperative care. We included all original studies and classi-
ﬁed them according to the 17 fast-track interventions proposed by the
Enhanced Recovery After Surgery Group. The primary endpoints were
median length of hospital stay (LOS), readmissions, morbidity andmortality.
Results: 13 studies reporting on a total of 1621 patients were found: 2
randomised control trials and a case-series in gastric surgery; 2 case-
control studies and a case-series in hepatic surgery; 2 case-series in
oesophageal surgery; 2 case-control studies and 3 case-series in pancreatic
surgery. The highest number of interventions implemented in gastric,
hepatic, oesophageal and pancreatic surgery were 13, 15, 5 and 12
respectively. In all types of upper gastrointestinal surgery studies
demonstrated a reduction in median length of stay ranging from 2-6 days,
without an increase in readmission rates, morbidity and mortality.
Conclusions: Initial studies show that fast-track surgery is feasible and
may reduce length of stay. However, high quality studies are required.
0552: AN AUDIT OF THE USE OF PET-CT AND FITNESS ASSESSMENT IN
PATIENTS WITH OESOPHAGO-GASTRIC CANCER
Emily Hotton, Srikant Ganesh, Natalie Blencowe, Robert Whistance, Sean
Strong, Jane Blazeby. University of Bristol, Bristol, UK
Aim: Accurate staging in oesophago-gastric (OG) cancer is essential for
patients considered for radical treatment. National guidelines recommend
that Positron Emission Tomography Computed Tomography (PET-CT) be
performed in all OG cancer patients without CT evidence of metastatic
disease and who are deemed ﬁt for curative treatment. This study assessed
adherence of the upper gastrointestinal (UGI) cancer multi-disciplinary
team (MDT) to this audit standard.Methods: A retrospective review of prospectively kept MDT records was
performed for consecutive patients with OG cancer discussed at the central
MDT between July 2008 and July 2010. Data collection included investi-
gations performed, treatment outcomes and patient ﬁtness.
Results: 102 MDT meetings discussed 460 patients with OG cancer of
whom 241 were primarily considered for curative treatment. Of these, 3
patients did not undergo PET-CT and reasons for this were unknown. 24
patients (10.0%) were subsequently considered unﬁt for curative treat-
ment. The audit target was met in 214 patients (88.7%).
Conclusion: Adherence to national PET-CT guidelines by the UGI MDT was
good. Unnecssary PET-CT staging was performed in a number of patients
ultimately deemed unﬁt for curative treatment. Early ﬁtness assessment in
the treatment pathwaycould improve compliancewithnational guidelines.
0553: AN AUDIT OF STAGING INVESTIGATIONS FOR PATIENTS
UNDERGOING CURATIVE TREATMENT IN OESOPHAGO-GASTRIC
CANCER
Srikant Ganesh, Emily Hotton, Natalie Blencowe, Robert Whistance, Jane
Blazeby, Sean Strong. University of Bristol, Bristol, UK
Aim: Current guidelines recommend the use of Positron Emission
Tomography Computed Tomography (PET-CT) in all ﬁt patients with
oesophago-gastric cancer (OGC), as part of the staging process. This study
assessed investigations performed on recommendation of the upper
gastrointestinal (UGI) cancer multi-disciplinary team (MDT) in patients
scheduled for curative treatment. Unnecessary investigations were
deﬁned as those undertaken in patients ultimately deemed unﬁt for
curative treatment.
Method: A review of MDT records was performed for consecutive patients
with OG cancer discussed between 2008 and 2010. Details of all staging
investigations and ﬁnal management decisions were evaluated.
Results: 460 OGC patients were discussed. 241 were initially considered
for curative treatment of which 24 were subsequently considered unﬁt. In
these patients, 31 unnecessary investigations were performed including 18
endoscopic ultrasounds (75.0%), 4 second CT scans (16.7%), 5 staging
laparoscopies (20.8%) and 4 additional investigations (16.7%).
Conclusion: Unnecessary staging investigations could have been avoided
in approximately 10% of patients with cost saving implications.
0581: COMPLICATIONS AFTER BARIATRIC SURGERY
Michail Chatzikonstantinou, Tereza Remesova, Cemal Kavasogullari, Pratik
Suﬁ. Whittington Hospital NHS trust, London, UK
Aim/Objective: To audit outcomes of bariatric surgery at North London
Obesity Surgery Service (NLOSS). Participants: All patients who underwent
elective bariatric surgery at NLOSS between January 2007 and October
2011
Main Outcome Measures. Mortality, overall un-planned readmission,
median length of stay in hospital according to type of operations, gender
and age.
Methods and data collection: A retrospective analysis of patient
outcomes was performed using 4-year discharge data. Of 463 patients, 313
were Laparoscopic Roux-en Y Gastric Bypass (67,6%), 129 Gastric Band
(57,8%) and 21 sleeve gastrectomy (5,4%). The patients for every procedure
were divided into three age groups, 17-40 years, 41-60 and older than 60
years old. We examined these three procedures separately and compared
mortality rates, median length of admission, and readmissions by age and
gender.
Results: The overall mortality rate was 0.86. The median length of stay for
gastric bypass and band was 4 days (0-34) and 2 (0-7) respectively and the
unplanned 28 day readmission rate was 10.8% and 8.7% respectively.
Conclusions:Our statistical results were similar to international guide-
lines, with no signiﬁcant difference with literature references.
0758: REMISSION OF TYPE 2 DIABETES FOLLOWING ROUX-EN-Y
GASTRIC BYPASS ACCORDING TO NEW GUIDELINES
Haritharan Nageswaran, Martin Nnaji, Dimitri J. Pournaras, David
Mahon, Richard Welbourn. Taunton and Somerset Foundation Trust,
Taunton, Somerset, UK
Aim: Bariatric surgery is considered a long-term solution to the rising
incidence of Type 2 Diabetes (T2DM) secondary to obesity, with a meta-
